June 12, 2007 - Ablation Frontiers, Inc., developer and manufacturer of three-dimensional catheters for the treatment of atrial fibrillation (AF), announced that it received the CE Mark for its Cardiac Ablation System consisting of a portfolio of anatomical based catheters and a uniquely designed radiofrequency (RF) energy delivery system, for which the company initiated the first commercial use of its Ablation System this year at key international cardiac centers throughout the European Union and other International markets that recognize the CE Mark.

June 12, 2007 — GE Healthcare introduced its ViewPoint Vascular comprehensive ultrasound data management solution for vascular labs at the Society of Vascular Surgeons (SVS)/Society of Vascular Ultrasound (SVU) annual meeting in Baltimore, Maryland.

June 12, 2007- Siemens Medical Solutions USA and Partners HealthCare announced that they have finalized an agreement in which the two organizations will collaborate to develop innovative Service-Oriented Architecture (SOA) infrastructure in healthcare IT.

June 12, 2007 — Response Biomedical Corporation today announced that it has been granted a medical device license by Health Canada to market its RAMP NT-proBNP Test.

The company currently markets the product in Europe and has applied for FDA clearance of the test in the United States.

June 12, 2007 - Recent findings show that the majority of people untrained in how to perform cardiopulmonary resuscitation, and even many trained emergency personnel, do not push with enough force to properly administer CPR.

June 12, 2007 — Dr. Ronald M. Fairman, principal investigator for the VALOR clinical study evaluating the Talent Thoracic Stent Graft System, today presented positive 12-month results at a late-breaking session during the annual meeting of the Society for Vascular Surgery in Baltimore.

June 11, 2007 — Cardio BioSciences and Mayo Clinic announced today that they have entered into a collaborative agreement related to the licensing of Mayo Clinic research, know-how and intellectual property in the field of cardiac commitment of stem cells, in a move that positions Cardio_ BioSciences as a global leader in the field of regenerative therapies for heart failure

June 8, 2007 — Haemoscope Corporation has developed PlateletMapping assays, combining automated platelet aggregation with the company’s proprietary TEG 5000 (Thrombelastograph) Hemostasis System.

The assays measure inhibited platelet function against maximum platelet function for optimal antiplatelet therapy and demonstrate the degree of inhibition by different platelet inhibitors as well as providing maximum platelet function, which can be used as a reference point for determining an anti-platelet regimen.

June 8, 2007 — CardiArc, Inc. has established a research and testing program in which CardiArc SPECT system devices will be loaned to healthcare research institutions. The company is seeking independent testing, evaluations in clinical settings and publication of results regarding the design and performance of its cardiovascular camera.

June 7, 2007 — NASA space technology is helping doctors diagnose and monitor treatments for hardening of the arteries in its early stages, before it causes heart attacks and strokes.

Hospitals and doctors around the country are using ArterioVision software initially developed at NASA's Jet Propulsion Laboratory (JPL) along with a standardized, painless, non-invasive ultrasound examination of the carotid artery, which carries blood from the heart to the brain.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now